关于我们
Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy has the potential to allow the body’s natural immune system to directly attack the cancer while enhancing the effects of other cancer treatments which may be used concurrently. At Immunicom we are reimagine how healing should be.
- 网站
-
https://www.immunicom.com/
Immunicom, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2013
地点
-
主要
获取路线
6048 Cornerstone Court West
Suite D
US，CA，San Diego，92121